COVID-19 Recovery Committee
Agenda: 02 December 2021
Thursday, 02 December 2021
13th Meeting, 2021
Full agenda and available meeting papers
1. Coronavirus (Discretionary Compensation for Self-isolation) (Scotland) Bill
The Committee will take evidence on the Bill at Stage 1 from—
- Sandra MacLeod
Chief Officer
Aberdeen City Health and Social Care Partnership - Michael Clancy
Director Law Reform
Law Society of Scotland - Mike Brewer
Deputy Chief Executive
Resolution Foundation - Susan McKellar
Operations Manager
Scottish Women’s Convention
Papers for this item:
Paper 1 - SPICe Paper (354KB, pdf) posted 29 November 2021
Paper 2 - Note by the Clerk (262KB, pdf) posted 30 November 2021
2. Ministerial statement on COVID-19; Subordinate legislation
The Committee will take evidence on the Ministerial statement on COVID-19; and the following instruments—
The Health Protection (Coronavirus) (International Travel and Operator Liability) (Scotland) Amendment (No. 7) Regulations 2021 (SSI 2021/425)
The Health Protection (Coronavirus) (Requirements) (Scotland) Amendment (No. 4) Regulations 2021 [draft] from—
- John Swinney
Deputy First Minister and Cabinet Secretary for COVID Recovery
Scottish Government - Professor Jason Leitch
National Clinical Director
Scottish Government - Elizabeth Sadler
Deputy Director, Covid Ready Society
Scottish Government
Papers for this item:
Paper 1 - Note by the Clerk (920KB, pdf) posted 29 November 2021
Paper 2 - SPICe Paper (348KB, pdf) posted 29 November 2021
Paper 3 - SPICe Paper (3MB, pdf) posted 06 December 2021
3. Subordinate legislation
John Swinney, Deputy First Minister and Cabinet Secretary for COVID Recovery to move—
S6M-02332—That the COVID-19 Recovery Committee recommends that the Health Protection (Coronavirus) (Requirements) (Scotland) Amendment (No. 4) Regulations 2021 [draft] be approved.
4. Consideration of evidence
The Committee will consider the evidence heard earlier in the meeting.
5. Work programme
The Committee will consider its work programme.
Papers for this item:
1 private paper will be discussed during this agenda item